• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

65.11 -3.85 (-5.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results ↗
October 29, 2024
 
Via Benzinga
News headline image
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views ↗
October 29, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 29, 2024
 
Via Benzinga
News headline image
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance ↗
October 29, 2024
GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. 
Via Benzinga
News headline image
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗
October 29, 2024
 
Via Benzinga
News headline image
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts ↗
October 16, 2024
 
Via Benzinga
News headline image
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics ↗
September 19, 2024
The company provides sequencing tools to help diagnose children with rare diseases. 
Via Investor's Business Daily
News headline image
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
October 29, 2024
From GeneDx
Via Business Wire
News headline image
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
October 24, 2024
From GeneDx
Via Business Wire
News headline image
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
October 08, 2024
From GeneDx
Via Business Wire
News headline image
Expert Ratings For GeneDx Hldgs ↗
July 17, 2024
 
Via Benzinga
News headline image
The Latest Analyst Ratings For GeneDx Hldgs ↗
June 26, 2024
 
Via Benzinga
News headline image
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
October 03, 2024
From GeneDx
Via Business Wire
News headline image
The Markets Are Ignoring Risk, But That Does Not Mean You Should... ↗
September 29, 2024
It is Fall clean-up time. Sell lagging and sagging companies. 
Via Talk Markets
News headline image
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 27, 2024
From GeneDx
Via Business Wire
News headline image
GeneDx to Participate in Fall Investor Conferences
August 12, 2024
From GeneDx
Via Business Wire
News headline image
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From GeneDx
Via Business Wire
News headline image
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024 ↗
July 30, 2024
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
July 30, 2024
From GeneDx
Via Business Wire
News headline image
GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
July 30, 2024
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing ↗
July 18, 2024
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. 
Via Benzinga
News headline image
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
July 11, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
7 Small-Cap Stocks With Massive Potential Returns ↗
July 06, 2024
Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries. 
Via InvestorPlace
News headline image
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
June 10, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying ↗
June 06, 2024
 
Via Benzinga
News headline image
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
June 05, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying ↗
May 29, 2024
 
Via Benzinga
News headline image
GeneDx to Participate in Upcoming Investor Conferences
May 22, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗
May 16, 2024
 
Via Benzinga
News headline image
Gold Down Over 2%; 3M Profit Beats Expectations ↗
April 30, 2024
 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap